Berberine as a potential therapeutic agent in the treatment of acute pancreatitis
Berberine (BRB) is a compound belonging to the group of isoquinoline alkaloids of plant origin that has long been used in traditional chinese medicine (TMC). Due to, among others anti-inflammatory properties BRB is a potential therapeutic in the treatment of acute pancreatitis (OZT). In a study in the mouse model of L-arginine-induced acute pancreatitis, we showed that BRB administered by the intravenous route at 0.1 and 0.5 mg / kg body weight significantly reduces the level of myeloperoxidase activity (an indicator of inflammation) in the pancreas and lungs. Promising results point to the need for larger, randomized studies to assess the long-term efficacy and side effects of BRB therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Postepy biochemii - 65(2019), 3 vom: 01. Okt., Seite 224-230 |
| Sprache: |
Polnisch |
|---|
| Weiterer Titel: |
Berberyna jako potencjalny terapeutyk w leczeniu ostrego zapalenia trzustki |
|---|
| Beteiligte Personen: |
Tarasiuk, Aleksandra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.10.2019 Date Revised 08.01.2020 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18388/pb.2019_278 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM302492445 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM302492445 | ||
| 003 | DE-627 | ||
| 005 | 20231225110834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||pol c | ||
| 024 | 7 | |a 10.18388/pb.2019_278 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1008.xml |
| 035 | |a (DE-627)NLM302492445 | ||
| 035 | |a (NLM)31643170 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a pol | ||
| 100 | 1 | |a Tarasiuk, Aleksandra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Berberine as a potential therapeutic agent in the treatment of acute pancreatitis |
| 246 | 3 | 3 | |a Berberyna jako potencjalny terapeutyk w leczeniu ostrego zapalenia trzustki |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.10.2019 | ||
| 500 | |a Date Revised 08.01.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Berberine (BRB) is a compound belonging to the group of isoquinoline alkaloids of plant origin that has long been used in traditional chinese medicine (TMC). Due to, among others anti-inflammatory properties BRB is a potential therapeutic in the treatment of acute pancreatitis (OZT). In a study in the mouse model of L-arginine-induced acute pancreatitis, we showed that BRB administered by the intravenous route at 0.1 and 0.5 mg / kg body weight significantly reduces the level of myeloperoxidase activity (an indicator of inflammation) in the pancreas and lungs. Promising results point to the need for larger, randomized studies to assess the long-term efficacy and side effects of BRB therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Berberine |2 NLM | |
| 650 | 7 | |a 0I8Y3P32UF |2 NLM | |
| 700 | 1 | |a Pawlik, Leon |e verfasserin |4 aut | |
| 700 | 1 | |a Fichna, Jakub |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Postepy biochemii |d 1954 |g 65(2019), 3 vom: 01. Okt., Seite 224-230 |w (DE-627)NLM000034541 |x 0032-5422 |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2019 |g number:3 |g day:01 |g month:10 |g pages:224-230 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18388/pb.2019_278 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2019 |e 3 |b 01 |c 10 |h 224-230 | ||